Intraocular sustained release drug delivery systems and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/5575 (2006.01) A61K 9/00 (2006.01) A61K 9/16 (2006.01) A61K 9/20 (2006.01) A61K 31/557 (2006.01) A61K 47/34 (2006.01) A61P 27/06 (2006.01)

Patent

CA 2756065

Biocompatible, bioerodible sustained release implants and microspheres for intracameral or anterior vitreal placement include an anti-hypertensive agent and a biodegradable polymer effective to treat an ocular hypertensive condition (such as glaucoma) by relapsing therapeutic amount of the anti-hypertensive agent over a period of time between days and 1 year.

L'invention concerne des implants et des microsphères biocompatibles, bioérodables à libération prolongée pour le placement intracaméral ou vitréen antérieur, qui comprennent un agent anti-hypertenseur et un polymère biodégradable efficaces pour traiter un état d'hypertension oculaire (comme un glaucome) par libération d'une quantité thérapeutique de l'agent anti-hypertenseur pendant une période de temps comprise entre 10 jours et 1 an.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Intraocular sustained release drug delivery systems and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intraocular sustained release drug delivery systems and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intraocular sustained release drug delivery systems and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2066175

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.